Publicación:
Infarto agudo de miocardio como manifestación inicial de síndrome antifosfolípido primario: Reporte de Caso

dc.contributor.authorPedraza Arévalo, Laura Camilaspa
dc.contributor.authorGuzmán, Renato A.spa
dc.date.accessioned2020-01-31T08:16:38Z
dc.date.accessioned2025-08-05T14:25:14Z
dc.date.available2020-01-31T08:16:38Z
dc.date.available2025-08-05T14:25:14Z
dc.date.issued2020-01-31
dc.description.abstractIntroducción. El síndrome antifosfolípido primario (SAF) suele manifestarse con trombosis venosas más que con arteriales, y entre estas últimas las comunes son a nivel cerebral, sin embargo, también pueden debutar con infarto agudo de miocardio (IAM). Por ello, es importante conocer el contexto en el cual sospechar eventos trombóticos como manifestación de SAF, en especial en el corazón dado que impactan en el pronóstico. El presente trabajo describe un caso de síndrome SAF en un hombre de 29 años que acude a urgencias con dolor en miembro inferior izquierdo asociado a signos de inflamación local que impiden la marcha, antecedente de SAF dado por 2 IAM y una trombosis venosa profunda (TVP) por lo cual estaba anticoagulado con cumarínico. El examen físico fue compatible con TVP izquierda, que luego se confirmó con Doppler, por lo que se considera una recurrencia de la enfermedad de base y se inicia manejo con heparina de bajo peso molecular; el paciente tiene una mejoría clínica al 5 día de hospitalización por lo que se da alta hospitalaria. A continuación, se discute el IAM como la primera manifestación de SAF, resaltando sus causas, presentación, manejo y pronóstico. spa
dc.description.abstractIntroduction. Primary antiphospholipid syndrome (APS) is commonly manifested with venous thrombosis more than with arterial thrombosis. In the latter, the most common thrombosis is cerebral, although it can debut with acute myocardial infarction (AMI). According to that, is important to know the context in which we must suspect thrombotic events as APS manifestation, especially in the heart taking into account the impact in the prognosis. This paper describes a case of APS in a 29-years-old male who was admitted in the emergency room with pain in the left lower limb associated to signs of local inflammation that blocks walking; history of primary APS due to 2 AMI and one deep venous thrombosis (DVT) whereby the patient was anticoagulated with coumarin. The physical exam was compatible with left DVT, that was confirmed after with Doppler, so there is considered a recurrence of the base disease and low molecular weight heparin was initiated. At fifth day of hospitalization, the patient had clinical improvement, so he was discharged. Next, AMI is discussed as first manifestation of APS, highlighting the causes, presentation, management and prognosis.eng
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.26752/cuarzo.v25.n2.444
dc.identifier.eissn2500-7181
dc.identifier.issn0121-2133
dc.identifier.urihttps://repositorio.juanncorpas.edu.co/handle/001/414
dc.identifier.urlhttps://doi.org/10.26752/cuarzo.v25.n2.444
dc.language.isospaspa
dc.publisherFundación Universitaria Juan N. Corpasspa
dc.relation.bitstreamhttps://revistas.juanncorpas.edu.co/index.php/cuarzo/article/download/444/428
dc.relation.citationendpage41
dc.relation.citationissue2spa
dc.relation.citationstartpage38
dc.relation.citationvolume25spa
dc.relation.ispartofjournalRevista Cuarzospa
dc.relation.referencesNegrini S, Pappalardo F, Murdaca G, et al. The antiphospholipid syndrome: from pathophysiology to treatment. Clin Exp Med. 2017;17(3):257-67.spa
dc.relation.referencesClinical manifestations of antiphospholipid syndrome - UpToDate [Internet]. [citado 21 de octubre de 2019]. Disponible en: https://www-uptodate-com.recursosenlinea.juanncorpas.edu.co:2443/contents/clinical-manifestations-of-antiphospholipid-syndrome?search=Clinical%20manifestations%20of%20antiphospholipid%20syndrome&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1spa
dc.relation.referencesMatyja-Bednarczyk A, Swadźba J, Iwaniec T, et al. Risk factors for arterial thrombosis in antiphospholipid syndrome. Thromb Res. 2014;133(2):173-6.spa
dc.relation.referencesNazir S, Tachamo N, Lohani S, et al Acute myocardial infarction and antiphospholipid antibody syndrome: a systematic review. Coron Artery Dis.2017;28(4):332-5.spa
dc.relation.referencesDavies JOJ, Hunt BJ. Myocardial infarction in young patients without coronary atherosclerosis: assume primary antiphospholipid syndrome until proved otherwise. Int J Clin Pract. 2007;61(3):379-84.spa
dc.relation.referencesOsula S, Bell GM, Hornung RS. Acute myocardial infarction in young adults: causes and management. Postgrad Med J. 2002;78(915):27-30.spa
dc.relation.referencesKolitz T, Shiber S, Sharabi I, et al. Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form. Front Immunol. 2019;10:941.spa
dc.relation.referencesCervera R, Piette J-C, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum.2002;46(4):1019-27.spa
dc.relation.referencesPrashanth P, Mukhaini M, Riyami A. A rare presentation of primary antiphospholipid syndrome. Oman Med J. 2009;24(4):300-2.spa
dc.relation.referencesHughes G. Hughes syndrome (antiphospholipid syndrome) and myocardial infarction. Int J Clin Pract. 2010;64(9):1183-4.spa
dc.relation.referencesGandhi H, Ahmed N, Spevack DM. Prevalence of myocardial infarction with non-obstructive coronary arteries (MINOCA) amongst acute coronary syndrome in patients with antiphospholipid syndrome. Int J Cardiol Heart Vasc. 2019;22:148-9.spa
dc.relation.referencesTakeuchi S, Obayashi T, Toyama J. Primary antiphospholipid syndrome with acute myocardial infarction recanalised by PTCA. Heart Br Card Soc. 1998;79(1):96-8.spa
dc.relation.referencesGrosso G, Sippl N, Kjellstrom B, et al. Antiphospholipid Antibodies in Patients With Myocardial Infarction. Ann Intern Med. 2019;170(4):277-80.spa
dc.relation.referencesGannon S, Hyder O. Treatment of ST elevation Myoccardial Infarction in Antiphospholipid Syndrome J Am Coll Cardiol. 2018;71(11 Supplement):A2196.spa
dc.relation.referencesErkan D, Lockshin MD. Antiphospholipid Syndrome. First. New York: Springer; 2017. Marti V, Seixo F, Santalo M, et al. Antiphospholipid syndrome and acute myocardial infarction: treatment with thrombectomy and abciximab. Rev Port Cardiol Orgao Of Soc Port Cardiol Port J Cardiol Off J Port Soc Cardiol. 2014;33(7-8):465.e1-4.spa
dc.relation.referencesGeorge D, Erkan D. Antiphospholipid syndrome. Prog Cardiovasc Dis. 2009;52(2):115-25.spa
dc.relation.referencesCervera R. Antiphospholipid syndrome. Thromb Res. 2017;151:S43-7.spa
dc.relation.referencesStepien K, Nowak K, Wypasek E, et al. High prevalence of inherited thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries: Comparison with cryptogenic stroke. Int J Cardiol. 2019;290:1-6.spa
dc.relation.referencesPerl L, Netzer A, Rechavia E, et al. Long-term outcome of patients with antiphospholipid syndrome who undergo percutaneous coronary intervention. Cardiology. 2012;122(2):76-82.spa
dc.relation.referencesTektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019;78(10):1296-304.spa
dc.relation.referencesNegrini S, Pappalardo F, Murdaca G, et al. The antiphospholipid syndrome: from pathophysiology to treatment. Clin Exp Med. 2017;17(3):257-67.spa
dc.relation.referencesKoniari I, Siminelakis SN, Baikoussis NG, et al. Antiphospholipid syndrome; its implication in cardiovascular diseases: a review. J Cardiothorac Surg. 2010;5:101.spa
dc.relation.referencesSmukowska-Gorynia A, Mularek-Kubzdela T, Araszkiewicz A. Recurrent acute myocardial infarction as an initial manifestation of antiphospholipid syndrome: treatment and management. Blood Coagul Fibrinolysis Int J Haemost Thromb. 2015;26(1):91-4.spa
dc.relation.referencesAbid L, Frikha F, Bahloul Z, et al. Acute myocardial infarction in young adults with antiphospholipid syndrome: report of two cases and literature review. Pan Afr Med J. 2011;8:13.spa
dc.relation.referencesHughes GR. The antiphospholipid syndrome: ten years on. Lancet Lond Engl. 1993;342(8867):341-4.spa
dc.relation.referencesDhibar DP, Sahu KK, Varma SC, et al. Intra-cardiac thrombus in antiphospholipid antibody syndrome: An unusual cause of fever of unknown origin with review of literature. J Cardiol Cases. 2016;14(5):153-6.spa
dc.relation.referencesWaisayarat J, Plumworasawat S, Vilaiyuk S, et al. Intracardiac thrombus in a patient with catastrophic antiphospholipid syndrome: an autopsy case report and review of the literature. Vasc Health Risk Manag. 2019;15:253-8.spa
dc.relation.referencesCakmak HA, Aslan S, Durmaz E, et al. Acute myocardial infarction due to antiphospholipid antibody syndrome in a young pregnant woman. J Cardiol Cases. 2011;4(1):e8-12.spa
dc.relation.referencesSharma AK, Baig MW, Heist EK. Intracardiac thrombosis and acute myocardial infarction as initial presentation of antiphospholipid syndrome. Am J Med Sci. 2011;342(3):254-6.spa
dc.relation.referencesUribe CE, Cárdenas JM, Cabrales J, et al. Infarto agudo del miocardio como primera manifestación del síndrome antifosfolípido primario en un paciente de veinticuatro años. Rev Colomb Cardiol. 2005;12(3):5. 32.spa
dc.rightsLaura Camila Pedraza Arévalo, Renato A. Guzmán - 2019spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.juanncorpas.edu.co/index.php/cuarzo/article/view/444spa
dc.subjectPrimary antiphospholipid syndromeeng
dc.subjectManifestationeng
dc.subjectAcute myocardial infarctioneng
dc.subjectSíndrome antifosfolípido primariospa
dc.subjectManifestaciónspa
dc.subjectInfarto agudo de miocardiospa
dc.titleInfarto agudo de miocardio como manifestación inicial de síndrome antifosfolípido primario: Reporte de Casospa
dc.title.translatedAcute myocardial infarction as initial manifestation of primary antiphospholipid syndrome: Case Reporteng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREFspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublicationspa

Archivos